N-SMase3 inhibitors are chemicals designed to selectively target and inhibit the activity of Neutral Sphingomyelinase 3 (N-SMase3), an enzyme involved in the hydrolysis of sphingomyelin to produce ceramide and phosphocholine. This enzymatic activity is a key component in the regulation of cellular processes, including signaling pathways that govern cell growth, differentiation, and apoptosis. N-SMase3 inhibitors can thus play a crucial role in modulating these pathways by controlling the production of ceramide, a lipid molecule known for its role in cellular signaling. The inhibition of N-SMase3 can lead to altered levels of ceramide, which in turn can affect various cellular functions and signaling mechanisms. These inhibitors are typically characterized by their ability to bind to the active site of N-SMase3 or to interact with its regulatory components, thereby reducing its activity. The development and study of N-SMase3 inhibitors involve rigorous biochemical and biophysical assays to assess their efficacy in inhibiting the enzyme and to understand their mechanism of action at a molecular level.
The research into N-SMase3 inhibitors encompasses a wide range of scientific techniques, including but not limited to, enzyme kinetics studies, molecular docking, and structural biology approaches to elucidate the interaction between the inhibitors and the enzyme. Advanced imaging and spectroscopy methods can also be employed to observe the effects of these inhibitors on cellular lipid composition and to study the downstream effects on cellular signaling pathways. Such research can provide valuable insights into the complex network of lipid-mediated signaling within cells and the role of ceramide as a critical mediator in these processes. By inhibiting N-SMase3, these chemicals can alter the ceramide balance within cells, thereby affecting the regulation of cellular functions mediated by this lipid. The study of N-SMase3 inhibitors is a dynamic field that contributes to our understanding of lipid metabolism and signaling, offering a detailed view of the molecular mechanisms that underpin critical cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $117.00 $469.00 | 18 | |
Inhibits ceramide synthase, potentially affecting the sphingolipid pathway and indirectly N-SMase3. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $106.00 | 8 | |
A potent inhibitor of serine palmitoyltransferase, could indirectly influence N-SMase3. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
An N-SMase inhibitor, though not specific for N-SMase3, could have indirect effects on N-SMase3. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Known to inhibit acid sphingomyelinase, could have indirect effects on N-SMase3. | ||||||
Imipramine hydrochloride | 113-52-0 | sc-207753 sc-207753B sc-207753A | 100 mg 1 g 5 g | $25.00 $44.00 $101.00 | 5 | |
A tricyclic antidepressant, inhibits acid sphingomyelinase, possibly impacting N-SMase3 indirectly. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $51.00 $292.00 | 3 | |
Shown to inhibit sphingomyelinase activity, potentially influencing N-SMase3. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Reported to modulate sphingolipid metabolism, possibly influencing N-SMase3. | ||||||